Strategic PR programme, to support Owlstone Medical with the establishment of the spin-out as a standalone company, and raise awareness with new investors, customers and potential partners in industry and academia. The program also needed to evidence breath analysis as a proven diagnostic test, positioning Owlstone as the leader in the field.

Client comments: “Zyme has provided us with strategic guidance and a very proactive approach in developing our PR and communications programme. Zyme’s industry knowledge and network of media contacts has created opportunities for us to build our profile and establish breath as a new diagnostic modality. We have been very impressed by the breadth and quality of media coverage achieved on a regular basis, in key trade publications and global business press.”

Founder and CEO, Owlstone Medical.